微小RNA在卵巢上皮性肿瘤中诊断及治疗的研究进展

卵巢上皮性肿瘤(EOC)是死亡率最高的妇科恶性肿瘤,也是导致妇女癌症死亡的第五大病因。为了延长晚期EOC患者的生存期,克服化疗耐药是治疗的重要措施。微小RNA(miRNAs)能调控与耐药相关的多种基因,是化疗耐药的研究热点。多种miRNAs在EOC中异常表达,联合检测血浆中miR-205和let-7f可以提高EOCⅠ期的诊断准确性;miR-484,miR-642,miR-217和miR-181a可预测耐药的发生,miR-509-3p,miR-145,miR-181a,miR-34可抑制铂类耐药细胞株的增殖;miR-34c是唯一的可作为无复发的独立预测标志物,miR-519与高级别浆液性癌(HG...

Full description

Saved in:
Bibliographic Details
Published in国际妇产科学杂志 Vol. 43; no. 5; pp. 502 - 505
Main Author 徐菲 钱莉莉 吴大保 周颖
Format Journal Article
LanguageChinese
Published 安徽医科大学附属省立医院妇产科, 合肥,230001 2016
Subjects
Online AccessGet full text
ISSN1674-1870

Cover

Abstract 卵巢上皮性肿瘤(EOC)是死亡率最高的妇科恶性肿瘤,也是导致妇女癌症死亡的第五大病因。为了延长晚期EOC患者的生存期,克服化疗耐药是治疗的重要措施。微小RNA(miRNAs)能调控与耐药相关的多种基因,是化疗耐药的研究热点。多种miRNAs在EOC中异常表达,联合检测血浆中miR-205和let-7f可以提高EOCⅠ期的诊断准确性;miR-484,miR-642,miR-217和miR-181a可预测耐药的发生,miR-509-3p,miR-145,miR-181a,miR-34可抑制铂类耐药细胞株的增殖;miR-34c是唯一的可作为无复发的独立预测标志物,miR-519与高级别浆液性癌(HGSOC)的低生存率有关。总结和讨论miRNAs在EOC诊断及治疗上的应用。
AbstractList 卵巢上皮性肿瘤(EOC)是死亡率最高的妇科恶性肿瘤,也是导致妇女癌症死亡的第五大病因。为了延长晚期EOC患者的生存期,克服化疗耐药是治疗的重要措施。微小RNA(miRNAs)能调控与耐药相关的多种基因,是化疗耐药的研究热点。多种miRNAs在EOC中异常表达,联合检测血浆中miR-205和let-7f可以提高EOCⅠ期的诊断准确性;miR-484,miR-642,miR-217和miR-181a可预测耐药的发生,miR-509-3p,miR-145,miR-181a,miR-34可抑制铂类耐药细胞株的增殖;miR-34c是唯一的可作为无复发的独立预测标志物,miR-519与高级别浆液性癌(HGSOC)的低生存率有关。总结和讨论miRNAs在EOC诊断及治疗上的应用。
卵巢上皮性肿瘤(EOC)是死亡率最高的妇科恶性肿瘤,也是导致妇女癌症死亡的第五大病因。为了延长晚期EOC患者的生存期,克服化疗耐药是治疗的重要措施。微小RNA(miRNAs)能调控与耐药相关的多种基因,是化疗耐药的研究热点。多种miRNAs在EOC中异常表达,联合检测血浆中miR-205和let-7f可以提高EOCⅠ期的诊断准确性;miR-484,miR-642,miR-217和miR-181a可预测耐药的发生,miR-509-3p,miR-145,miR-181a,miR-34可抑制铂类耐药细胞株的增殖;miR-34c是唯一的可作为无复发的独立预测标志物,miR-519与高级别浆液性癌(HGSOC)的低生存率有关。总结和讨论miRNAs在EOC诊断及治疗上的应用。
Abstract_FL Epithelial ovarian tumor (EOC) is the most lethal gynecologic malignancy, and it is the fifth leading cause of cancer deaths in women. In order to improve survival in women with advanced EOC, it is important to overcome the drug resistance. miRNAs can act on multiple genes associated with a chemoresistant phenotype, which have been the promising tools in this regard. miRNAs deregulation has been identified as an important feature in EOC. Combination of miR-205 and let-7f expression in plasma samples of EOC patients provided high diagnostic accuracy for stage Ⅰdisease in EOC;miR-484, miR-642, miR-217 and miR-181a can predict resistance, miR-509-3p, miR-145, miR-181a miR-34 can inhibit proliferation of platinum resistant cell lines;miR-34c is the only markers as predictor of relapse, miR-519 is related with low survival rate. The function of miRNAs as prognostic and therapeutic tools in EOC was summarized here.
Author 徐菲 钱莉莉 吴大保 周颖
AuthorAffiliation 安徽医科大学附属省立医院妇产科,合肥230001
AuthorAffiliation_xml – name: 安徽医科大学附属省立医院妇产科, 合肥,230001
Author_FL XU Fei
WU Da-bao
ZHOU Ying
QIAN Li-li
Author_FL_xml – sequence: 1
  fullname: XU Fei
– sequence: 2
  fullname: QIAN Li-li
– sequence: 3
  fullname: WU Da-bao
– sequence: 4
  fullname: ZHOU Ying
Author_xml – sequence: 1
  fullname: 徐菲 钱莉莉 吴大保 周颖
BookMark eNotjstKw0AYhWdRwVr7Ei6FwNwySZa1eIOiIN2Hv5NMjJdEW6TtTsRVQbrRKtWFiKAuWi-gFgT7Mp0mj2GgwoGz-fjOWUC5KI78HMoTYXGD2BaeR8VGI6xhTDFzBOd5tKJ_h_qtu7NV0nfP-uJTfz9MRp2kP5yePqVn4-TmcTIapK-daW-gu53px0_Su07658n9ZfLylY5v9fvVIppTcNDwi_9dQNW11Wp5w6hsr2-WSxVDCmoaPgEfuF8j4GTBpnSk8hybElMRxamSgAUwT3GbMs8CUcv-geUAcItR7ktWQMszbRMiBVHg7sUn9SgbdINmu-Uqud-imAhsYmxm8NIMlrtxFByHGX5UDw-h3naFhant2IyyPy3Fa8c
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Progress in the Diagnosis and Treatment of miRNAs in Epithelial Ovarian Tumors
DocumentTitle_FL Progress in the Diagnosis and Treatment of miRNAs in Epithelial Ovarian Tumors
EndPage 505
ExternalDocumentID gwyx_fckx201605005
670289832
GrantInformation_xml – fundername: 国家自然科学基金; 安徽省自然科学基金; 安徽省科技厅年度重点科研项目
  funderid: (81001168,81272881); (1308085MH122); (1301043053)
GroupedDBID 2RA
92L
ALMA_UNASSIGNED_HOLDINGS
CDYEO
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
ID FETCH-LOGICAL-c625-e1aea4eb1a91a905c9cfd98215f1f42fca06a3df4823d7a6b964a79aa47324ec3
ISSN 1674-1870
IngestDate Thu May 29 04:07:05 EDT 2025
Wed Feb 14 10:15:32 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Drug resistance,neoplasm
肿瘤标记,生物学
卵巢肿瘤
抗药性,肿瘤
Tumor markers,biological
Ovarian neoplasms
MicroRNAs
微RNAs
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c625-e1aea4eb1a91a905c9cfd98215f1f42fca06a3df4823d7a6b964a79aa47324ec3
Notes Tumor markers,biological;Drug resistance,neoplasm;Ovarian neoplasms;MicroRNAs
12-1399/R
Epithelial ovarian tumor (EOC) is the most lethal gynecologic malignancy, and it is the fifth leading cause of cancer deaths in women. In order to improve survival in women with advanced EOC, it is important to overcome the drug resistance. miRNAs can act on multiple genes associated with a chemoresistant phenotype, which have been the promising tools in this regard. miRNAs deregulation has been identified as an important feature in EOC. Combination of miR-205 and let-7f expression in plasma samples of EOC patients provided high diagnostic accuracy for stage Ⅰdisease in EOC;miR-484, miR-642, miR-217 and miR-181a can predict resistance, miR-509-3p, miR-145, miR-181a miR-34 can inhibit proliferation of platinum resistant cell lines;miR-34c is the only markers as predictor of relapse, miR-519 is related with low survival rate. The function of miRNAs as prognostic and therapeutic tools in EOC was summarized here.
XU Fei, QIAN Li-
PageCount 4
ParticipantIDs wanfang_journals_gwyx_fckx201605005
chongqing_primary_670289832
PublicationCentury 2000
PublicationDate 2016
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – year: 2016
  text: 2016
PublicationDecade 2010
PublicationTitle 国际妇产科学杂志
PublicationTitleAlternate Foreign Medical Sciences(Obstet Gynecol Fascicle)
PublicationYear 2016
Publisher 安徽医科大学附属省立医院妇产科, 合肥,230001
Publisher_xml – name: 安徽医科大学附属省立医院妇产科, 合肥,230001
SSID ssib002039644
ssib008858041
ssib005319428
ssib051371002
ssib025873268
ssib008679380
ssib002039729
ssib010102505
ssib017477451
ssib036437542
Score 2.0202339
Snippet ...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 502
SubjectTerms 卵巢肿瘤
微RNAs
抗药性,肿瘤
肿瘤标记,生物学
Title 微小RNA在卵巢上皮性肿瘤中诊断及治疗的研究进展
URI http://lib.cqvip.com/qk/94965A/201605/670289832.html
https://d.wanfangdata.com.cn/periodical/gwyx-fckx201605005
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9VAFA6lbtyIomJ9UdBZlUge81zO9OZSBLuQCt1d5ubetCDc-mixdiXiqiDdaJXqQkRQF60PUAsF-2ea3v4Mz5k8bhYiKoQwmZP5cjJncvJNJnPG8672U2qZZdJnQgQ-zQT3VWx78MQDO7AcGSt-Grgxy2du0evzbH5sbK_x19LKcvdauvbbeSX_Y1XIA7viLNl_sGwNChmQBvvCHiwM-7-yMUkYMQnRiUsERLZvzmpMq2miJSZkixjmpILoiCSUGEkknCOI0q4gx38dtCAJ5EfEtJ1IEk3Lk3ULRbrtSnGiuMsB5CrHQCnjSoFUlMiSYkIHRBUJRQxHHMBXxukTkmLZy4oZO7UNMQCuiFJEOrU1qCecJtopKXCvQidqoRRVaqHmiAng9Wu1rBsVuDtrg5pTDjnCS2NWQqSqE1Pu8gEx1EFTdzHqEFuFLHQ1qrAWi8Vxq28lxSTO0rFzQf1QFouUVJ6_CBBVtnDWcOMsiBqMgAVs9Las_2HkAgdpwSHC-x9Ynhz3jmnTMu0R-QlixZvkCY6bY6To_ZqdPwx9GDe8qZQMg0NVxyFG_2Mj7wxdSaDuozHdiEkBXLzGi3FItlreGI5ZGGMkJzf8X1UGBhRZXBos3AWa5GatDTI7WGgQrLmT3omyZzSpi2Z-yhtbWzztmfznTv55A5p1_vpD_vRb_uPtwe76cGvn8NH7o8f7w5fvDna3jz6tH25u5xvrh1_3hpsvhltPhm-eDT9-P9p_lX95fsabaydz0zN-ueyHn0Jn3O-Htm8pUAirYAtYqtKspyRQ0yzMaJSlNuA27mVURnFPWN6FSrZCWUvh9mk_jc9644OlQf-cNylsV8acZ0B6e1R0oy7laZSGKgUsK9JowrtQ337nThHdpVPbdcK7UlZIp3zm73cWHjxc7WTp7VVsXQEDI57_I8YF7zieWXyzu-iNL99b6V8CFrvcvVw2l18hi3iB
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%BE%AE%E5%B0%8FRNA%E5%9C%A8%E5%8D%B5%E5%B7%A2%E4%B8%8A%E7%9A%AE%E6%80%A7%E8%82%BF%E7%98%A4%E4%B8%AD%E8%AF%8A%E6%96%AD%E5%8F%8A%E6%B2%BB%E7%96%97%E7%9A%84%E7%A0%94%E7%A9%B6%E8%BF%9B%E5%B1%95&rft.jtitle=%E5%9B%BD%E9%99%85%E5%A6%87%E4%BA%A7%E7%A7%91%E5%AD%A6%E6%9D%82%E5%BF%97&rft.au=%E5%BE%90%E8%8F%B2+%E9%92%B1%E8%8E%89%E8%8E%89+%E5%90%B4%E5%A4%A7%E4%BF%9D+%E5%91%A8%E9%A2%96&rft.date=2016&rft.issn=1674-1870&rft.volume=43&rft.issue=5&rft.spage=502&rft.epage=505&rft.externalDocID=670289832
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F94965A%2F94965A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fgwyx-fckx%2Fgwyx-fckx.jpg